Tag: Iovance

Biotechnology firm Iovance is undertaking a significant corporate overhaul in response to challenging market conditions following its recent product launch. ...

Iovance Biotherapeutics experienced a severe sell-off in the most recent trading session, with its shares plummeting 4.7 percent. The decline ...

Iovance Biotherapeutics' stock remains entrenched in a pronounced downward trajectory, with shares declining an additional 3.3% in the latest trading ...

Iovance Biotherapeutics has made a significant corporate announcement, detailing the issuance of new stock options. This move directly impacts the ...

Iovance Biotherapeutics shares are experiencing significant downward pressure after the company's latest quarterly results fell short of market expectations. The ...

Iovance Biotherapeutics is confronting a severe equity downturn, with its stock value declining by 69% since the start of the ...

Iovance Biotherapeutics finds itself navigating a complex landscape where significant regulatory achievements contrast sharply with persistent financial headwinds. The company's ...

A significant regulatory milestone in Canada has propelled Iovance Biotherapeutics' stock upward, with Health Canada granting market authorization for the ...

Iovance Biotherapeutics shares experienced a dramatic rally on Friday, closing the trading session with a substantial 13% gain at $2.49. ...

Iovance Biotherapeutics shares are confronting significant pressure from three distinct fronts as the company prepares to present at today's Wells ...